Cargando…
Quillaja saponin variants with central glycosidic linkage modifications exhibit distinct conformations and adjuvant activities
Immunological adjuvants such as the saponin natural product QS-21 help stimulate the immune response to co-administered antigens and have become increasingly important in the development of prophylactic and therapeutic vaccines. However, clinical use of QS-21 is encumbered by chemical instability, d...
Autores principales: | Walkowicz, William E., Fernández-Tejada, Alberto, George, Constantine, Corzana, Francisco, Jiménez-Barbero, Jesús, Ragupathi, Govind, Tan, Derek S., Gin, David Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800320/ https://www.ncbi.nlm.nih.gov/pubmed/27014435 http://dx.doi.org/10.1039/c5sc02978c |
Ejemplares similares
-
Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014) -
Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities
por: Fleck, Juliane Deise, et al.
Publicado: (2019) -
Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses
por: Cibulski, Samuel Paulo, et al.
Publicado: (2018) -
Phytotoxicity of Quillaja lancifolia Leaf Saponins and Their Bioherbicide Potential
por: Marques, Maria E. M., et al.
Publicado: (2023) -
ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines
por: Rivera-Patron, Mariana, et al.
Publicado: (2021)